Feasibility of de-escalation of axillary surgery in ycN0 breast cancer patients post NAC for cN2, cN3 disease: evaluating the concordance between ypN status from TAD and ALND
Categories (click each to see list of all clinical trials associated with that category): Breast (ONC), FPBCC CTO Studies, Surgical Oncology (SURGONC)
Current Status: Not open
Phase: N/A (Cancer Control)
Principal Investigator: Millen, Janelle-Cheri
Contact Information:
Brandy Bach
brbach@unmc.edu
Summary
Primary:
-To evaluate the pathologic concordance between pathologic nodal status (ypN) derived from targeted axillary dissection (TAD) and axillary lymph node dissection (ALND) in breast cancer patients with advanced nodal disease at presentation (cN2/cN3) who convert to clinically node negative (ycN0) following completion of neoadjuvant systemic therapy (NST)
Secondary:
-To determine changes in adjuvant treatment recommendations based on ypN from TAD versus ALND